-
Mashup Score: 3
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Taking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19 symptom onset—not earlier or later—may result in the greatest reduction in viral loads, viral transmission, and viral rebound in hospitalized patients, a University of Hong Kong–led study finds. For the study, posted by eLife, which publishes peer-reviewed preprints, the investigators fitted a mathematical model of in vivo Omicron variant
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 3Paxlovid use tied to 84% lower risk of hospital care - 2 month(s) ago
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 3Paxlovid use tied to 84% lower risk of hospital care - 2 month(s) ago
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 3Paxlovid use tied to 84% lower risk of hospital care - 2 month(s) ago
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2Why Aren't More Doctors Prescribing Paxlovid to High-Risk Patients? - 3 month(s) ago
It’s not all about drug-drug interactions, experts say
Source: www.medpagetoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 14Researchers race to develop Paxlovid replacement - 4 month(s) ago
Researchers from Rutgers believe themselves among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—the antiviral medication that helps keep high-risk patients …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Mixed Signals for Paxlovid and Long COVID Risk in CDC Study - 6 month(s) ago
Antiviral protected older at-risk patients, but appeared to increase risk in teens
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: People with obesity harmed by exclusion from studies; Teva sues Colorado over 'unconstitutional' program - 6 month(s) ago
People with obesity often go underrepresented in drug trials, a critical gap that researchers say leaves doctors unsure of efficacy or risks in that population.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Health discussion: Paxlovid for COVID - 7 month(s) ago
9NEWS Medical Expert Dr. Payal Kohli discusses what Paxlovid is and how it works to treat COVID-19. More local videos here: https://youtube.com/@9news Subscr…
Source: www.youtube.comCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0Stanford Study of Paxlovid for Long COVID Stopped Early - 10 month(s) ago
Enrollment was halted earlier than planned after interim analysis
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
RT @NcAging: @cidrap: Data: Optimal initiation of #Paxlovid in hospitalized COVID patients is 3 to 5 days | CIDRAP https://t.co/5zAgniUF9P